Two HIV drugs suspected of producing higher cardiovascular risk

March 31, 2008

FDA is looking at whether Ziagen and Videx is linked to more heart attacks.

A study has found that abacavir (Ziagen, GlaxoSmithKline) and didanosine (Videx, Bristol-Myers Squibb) are associated with an increased risk of heart attack. So the Food & Drug Administration has issued an early